Skip to main content
Top
Published in: Pathology & Oncology Research 4/2019

01-10-2019 | Original Article

Age-Related Hearing Impairment Associated NAT2, GRM7, GRHL2 Susceptibility Gene Polymorphisms and Haplotypes in Roma and Hungarian Populations

Authors: Petra Matyas, Etelka Postyeni, Katalin Komlosi, Renata Szalai, Judit Bene, Lili Magyari, Bela Melegh, Kinga Hadzsiev

Published in: Pathology & Oncology Research | Issue 4/2019

Login to get access

Abstract

Age-related hearing impairment (ARHI) is the most frequent sensory disease in the elderly, which is caused by an interaction between genetic and environmental factors. Here we examined the ethnic differences, allele and genotype frequencies of the NAT2, GRM7, and GRHL2 genes pooled samples of healthy Hungarian and healthy and hearing impaired Roma people. Study populations of healthy Hungarian and Roma subjects were characterized for the rs1799930 NAT2, rs11928865 GRM7, rs10955255, rs13263539, and rs1981361 GRHL2 polymorphisms and deaf Roma subjects were characterized for the rs1799930 NAT2, rs13263539, and rs1981361 GRHL2 using a PCR-RFLP method. We found significant differences in minor allele frequencies for GRHL2 rs13263539 and rs1981361 polymorphism between healthy Roma and Hungarian samples (37.9% vs. 51.0% and 43.6% vs. 56.2%, respectively; p < 0.05). The differences of homozygous genotype of GRHL2 rs13263539 and rs1981361 variants, values were also significantly different (13.0% vs. 25.3% and 16.5 vs. 32.3%; p < 0.05). The NAT2 rs1799930 homozygous genotype was 14.0% in healthy Romas and 7.7% in Hungarians, while the minor A allele frequency was 38.0% and 26.7% in Roma and Hungarian population, respectively (p < 0.05). Furthermore, the frequency of GGT, GAC and GAT haplotypes was significantly higher in the Hungarian population than in healthy Roma (1.87 vs. 4.47%, 0.91 vs. 2.07% and 1.15 vs. 5.51%, respectively; p < 0.008). Present study revealed significant interethnic differences in allele polymorphisms of NAT2, GRM7 and GRHL2 exhibit quite marked ethnic differences in Roma populations that might have important implications for the preventive and therapeutic treatments in this population.
Literature
1.
go back to reference Staecker H, Zheng QY, Van De Water TR (2001) Oxidative stress in aging in the C57B16/J mouse cochlea. Acta Otolaryngol 121(6):666–672CrossRef Staecker H, Zheng QY, Van De Water TR (2001) Oxidative stress in aging in the C57B16/J mouse cochlea. Acta Otolaryngol 121(6):666–672CrossRef
2.
go back to reference Cruickshanks KJ, Wiley TL, Tweed TS, Klein BE, Klein R, Mares-Perlman JA, Nondahl DM (1998) Prevalence of hearing loss in older adults in beaver dam, Wisconsin. The epidemiology of hearing loss study. Am J Epidemiol 148(9):879–886CrossRef Cruickshanks KJ, Wiley TL, Tweed TS, Klein BE, Klein R, Mares-Perlman JA, Nondahl DM (1998) Prevalence of hearing loss in older adults in beaver dam, Wisconsin. The epidemiology of hearing loss study. Am J Epidemiol 148(9):879–886CrossRef
3.
go back to reference Unal M, Tamer L, Dogruer ZN, Yildirim H, Vayisoglu Y, Camdeviren H (2005) N-acetyltransferase 2 gene polymorphism and presbycusis. Laryngoscope 115(12):2238–2241CrossRef Unal M, Tamer L, Dogruer ZN, Yildirim H, Vayisoglu Y, Camdeviren H (2005) N-acetyltransferase 2 gene polymorphism and presbycusis. Laryngoscope 115(12):2238–2241CrossRef
4.
go back to reference Yamasoba T, Lin FR, Someya S, Kashio A, Sakamoto T, Kondo K (2013) Current concepts in age-related hearing loss: epidemiology and mechanistic pathways. Hear Res 303:30–38CrossRef Yamasoba T, Lin FR, Someya S, Kashio A, Sakamoto T, Kondo K (2013) Current concepts in age-related hearing loss: epidemiology and mechanistic pathways. Hear Res 303:30–38CrossRef
5.
go back to reference Seidman MD, Khan MJ, Tang WX, Quirk WS (2002) Influence of lecithin on mitochondrial DNA and age-related hearing loss. Otolaryngol Head Neck Surg 127(3):138–144CrossRef Seidman MD, Khan MJ, Tang WX, Quirk WS (2002) Influence of lecithin on mitochondrial DNA and age-related hearing loss. Otolaryngol Head Neck Surg 127(3):138–144CrossRef
6.
go back to reference Van Eyken E, Van Camp G, Fransen E, Topsakal V, Hendrickx JJ, Demeester K, Van de Heyning P, Maki-Torkko E, Hannula S, Sorri M, Jensen M, Parving A, Bille M, Baur M, Pfister M, Bonaconsa A, Mazzoli M, Orzan E, Espeso A, Stephens D, Verbruggen K, Huyghe J, Dhooge I, Huygen P, Kremer H, Cremers CW, Kunst S, Manninen M, Pyykko I, Lacava A, Steffens M, Wienker TF, Van Laer L (2007) Contribution of the N-acetyltransferase 2 polymorphism NAT2*6A to age-related hearing impairment. J Med Genet 44(9):570–578CrossRef Van Eyken E, Van Camp G, Fransen E, Topsakal V, Hendrickx JJ, Demeester K, Van de Heyning P, Maki-Torkko E, Hannula S, Sorri M, Jensen M, Parving A, Bille M, Baur M, Pfister M, Bonaconsa A, Mazzoli M, Orzan E, Espeso A, Stephens D, Verbruggen K, Huyghe J, Dhooge I, Huygen P, Kremer H, Cremers CW, Kunst S, Manninen M, Pyykko I, Lacava A, Steffens M, Wienker TF, Van Laer L (2007) Contribution of the N-acetyltransferase 2 polymorphism NAT2*6A to age-related hearing impairment. J Med Genet 44(9):570–578CrossRef
7.
go back to reference Bared A, Ouyang X, Angeli S, Du LL, Hoang K, Yan D, Liu XZ (2010) Antioxidant enzymes, presbycusis, and ethnic variability. Otolaryngol Head Neck Surg 143(2):263–268CrossRef Bared A, Ouyang X, Angeli S, Du LL, Hoang K, Yan D, Liu XZ (2010) Antioxidant enzymes, presbycusis, and ethnic variability. Otolaryngol Head Neck Surg 143(2):263–268CrossRef
8.
go back to reference Pujol R, Rebillard G, Puel JL, Lenoir M, Eybalin M, Recasens M (1990) Glutamate neurotoxicity in the cochlea: a possible consequence of ischaemic or anoxic conditions occurring in ageing. Acta Otolaryngol Suppl 476:32–36PubMed Pujol R, Rebillard G, Puel JL, Lenoir M, Eybalin M, Recasens M (1990) Glutamate neurotoxicity in the cochlea: a possible consequence of ischaemic or anoxic conditions occurring in ageing. Acta Otolaryngol Suppl 476:32–36PubMed
9.
go back to reference Friedman RA, Van Laer L, Huentelman MJ, Sheth SS, Van Eyken E, Corneveaux JJ, Tembe WD, Halperin RF, Thorburn AQ, Thys S, Bonneux S, Fransen E, Huyghe J, Pyykko I, Cremers CW, Kremer H, Dhooge I, Stephens D, Orzan E, Pfister M, Bille M, Parving A, Sorri M, Van de Heyning PH, Makmura L, Ohmen JD, Linthicum FH, Jr., Fayad JN, Pearson JV, Craig DW, Stephan DA, Van Camp G (2009) GRM7 variants confer susceptibility to age-related hearing impairment. Hum Mol Genet 18 (4):785–796CrossRef Friedman RA, Van Laer L, Huentelman MJ, Sheth SS, Van Eyken E, Corneveaux JJ, Tembe WD, Halperin RF, Thorburn AQ, Thys S, Bonneux S, Fransen E, Huyghe J, Pyykko I, Cremers CW, Kremer H, Dhooge I, Stephens D, Orzan E, Pfister M, Bille M, Parving A, Sorri M, Van de Heyning PH, Makmura L, Ohmen JD, Linthicum FH, Jr., Fayad JN, Pearson JV, Craig DW, Stephan DA, Van Camp G (2009) GRM7 variants confer susceptibility to age-related hearing impairment. Hum Mol Genet 18 (4):785–796CrossRef
10.
go back to reference Vona B, Nanda I, Neuner C, Muller T, Haaf T (2013) Confirmation of GRHL2 as the gene for the DFNA28 locus. Am J Med Genet A 161A(8):2060–2065CrossRef Vona B, Nanda I, Neuner C, Muller T, Haaf T (2013) Confirmation of GRHL2 as the gene for the DFNA28 locus. Am J Med Genet A 161A(8):2060–2065CrossRef
11.
go back to reference Peters LM, Anderson DW, Griffith AJ, Grundfast KM, San Agustin TB, Madeo AC, Friedman TB, Morell RJ (2002) Mutation of a transcription factor, TFCP2L3, causes progressive autosomal dominant hearing loss, DFNA28. Hum Mol Genet 11(23):2877–2885CrossRef Peters LM, Anderson DW, Griffith AJ, Grundfast KM, San Agustin TB, Madeo AC, Friedman TB, Morell RJ (2002) Mutation of a transcription factor, TFCP2L3, causes progressive autosomal dominant hearing loss, DFNA28. Hum Mol Genet 11(23):2877–2885CrossRef
12.
go back to reference Van Laer L, Van Eyken E, Fransen E, Huyghe JR, Topsakal V, Hendrickx JJ, Hannula S, Maki-Torkko E, Jensen M, Demeester K, Baur M, Bonaconsa A, Mazzoli M, Espeso A, Verbruggen K, Huyghe J, Huygen P, Kunst S, Manninen M, Konings A, Diaz-Lacava AN, Steffens M, Wienker TF, Pyykko I, Cremers CW, Kremer H, Dhooge I, Stephens D, Orzan E, Pfister M, Bille M, Parving A, Sorri M, Van de Heyning PH, Van Camp G (2008) The grainyhead like 2 gene (GRHL2), alias TFCP2L3, is associated with age-related hearing impairment. Hum Mol Genet 17(2):159–169CrossRef Van Laer L, Van Eyken E, Fransen E, Huyghe JR, Topsakal V, Hendrickx JJ, Hannula S, Maki-Torkko E, Jensen M, Demeester K, Baur M, Bonaconsa A, Mazzoli M, Espeso A, Verbruggen K, Huyghe J, Huygen P, Kunst S, Manninen M, Konings A, Diaz-Lacava AN, Steffens M, Wienker TF, Pyykko I, Cremers CW, Kremer H, Dhooge I, Stephens D, Orzan E, Pfister M, Bille M, Parving A, Sorri M, Van de Heyning PH, Van Camp G (2008) The grainyhead like 2 gene (GRHL2), alias TFCP2L3, is associated with age-related hearing impairment. Hum Mol Genet 17(2):159–169CrossRef
13.
go back to reference Morar B, Gresham D, Angelicheva D, Tournev I, Gooding R, Guergueltcheva V, Schmidt C, Abicht A, Lochmuller H, Tordai A, Kalmar L, Nagy M, Karcagi V, Jeanpierre M, Herczegfalvi A, Beeson D, Venkataraman V, Warwick Carter K, Reeve J, de Pablo R, Kucinskas V, Kalaydjieva L (2004) Mutation history of the roma/gypsies. Am J Hum Genet 75(4):596–609CrossRef Morar B, Gresham D, Angelicheva D, Tournev I, Gooding R, Guergueltcheva V, Schmidt C, Abicht A, Lochmuller H, Tordai A, Kalmar L, Nagy M, Karcagi V, Jeanpierre M, Herczegfalvi A, Beeson D, Venkataraman V, Warwick Carter K, Reeve J, de Pablo R, Kucinskas V, Kalaydjieva L (2004) Mutation history of the roma/gypsies. Am J Hum Genet 75(4):596–609CrossRef
14.
go back to reference Gresham D, Morar B, Underhill PA, Passarino G, Lin AA, Wise C, Angelicheva D, Calafell F, Oefner PJ, Shen P, Tournev I, de Pablo R, Kucinskas V, Perez-Lezaun A, Marushiakova E, Popov V, Kalaydjieva L (2001) Origins and divergence of the Roma (gypsies). Am J Hum Genet 69(6):1314–1331CrossRef Gresham D, Morar B, Underhill PA, Passarino G, Lin AA, Wise C, Angelicheva D, Calafell F, Oefner PJ, Shen P, Tournev I, de Pablo R, Kucinskas V, Perez-Lezaun A, Marushiakova E, Popov V, Kalaydjieva L (2001) Origins and divergence of the Roma (gypsies). Am J Hum Genet 69(6):1314–1331CrossRef
15.
go back to reference Hajioff S, McKee M (2000) The health of the Roma people: a review of the published literature. J Epidemiol Community Health 54(11):864–869CrossRef Hajioff S, McKee M (2000) The health of the Roma people: a review of the published literature. J Epidemiol Community Health 54(11):864–869CrossRef
16.
go back to reference Seidman MD, Khan MJ, Dolan DF, Quirk WS (1996) Age-related differences in cochlear microcirculation and auditory brain stem response. Arch Otolaryngol Head Neck Surg 122(11):1221–1226CrossRef Seidman MD, Khan MJ, Dolan DF, Quirk WS (1996) Age-related differences in cochlear microcirculation and auditory brain stem response. Arch Otolaryngol Head Neck Surg 122(11):1221–1226CrossRef
17.
go back to reference Gates GA, Couropmitree NN, Myers RH (1999) Genetic associations in age-related hearing thresholds. Arch Otolaryngol Head Neck Surg 125(6):654–659CrossRef Gates GA, Couropmitree NN, Myers RH (1999) Genetic associations in age-related hearing thresholds. Arch Otolaryngol Head Neck Surg 125(6):654–659CrossRef
18.
go back to reference Coling DE, Yu KC, Somand D, Satar B, Bai U, Huang TT, Seidman MD, Epstein CJ, Mhatre AN, Lalwani AK (2003) Effect of SOD1 overexpression on age- and noise-related hearing loss. Free Radic Biol Med 34(7):873–880CrossRef Coling DE, Yu KC, Somand D, Satar B, Bai U, Huang TT, Seidman MD, Epstein CJ, Mhatre AN, Lalwani AK (2003) Effect of SOD1 overexpression on age- and noise-related hearing loss. Free Radic Biol Med 34(7):873–880CrossRef
19.
go back to reference Ates NA, Unal M, Tamer L, Derici E, Karakas S, Ercan B, Pata YS, Akbas Y, Vayisoglu Y, Camdeviren H (2005) Glutathione S-transferase gene polymorphisms in presbycusis. Otol Neurotol 26(3):392–397CrossRef Ates NA, Unal M, Tamer L, Derici E, Karakas S, Ercan B, Pata YS, Akbas Y, Vayisoglu Y, Camdeviren H (2005) Glutathione S-transferase gene polymorphisms in presbycusis. Otol Neurotol 26(3):392–397CrossRef
20.
go back to reference Pujol R, Puel JL, Gervais d'Aldin C, Eybalin M (1993) Pathophysiology of the glutamatergic synapses in the cochlea. Acta Otolaryngol 113(3):330–334CrossRef Pujol R, Puel JL, Gervais d'Aldin C, Eybalin M (1993) Pathophysiology of the glutamatergic synapses in the cochlea. Acta Otolaryngol 113(3):330–334CrossRef
21.
go back to reference Steinbach S, Lutz J (2007) Glutamate induces apoptosis in cultured spiral ganglion explants. Biochem Biophys Res Commun 357(1):14–19CrossRef Steinbach S, Lutz J (2007) Glutamate induces apoptosis in cultured spiral ganglion explants. Biochem Biophys Res Commun 357(1):14–19CrossRef
22.
go back to reference Sipeky C, Matyas P, Melegh M, Janicsek I, Szalai R, Szabo I, Varnai R, Tarlos G, Ganczer A, Melegh B (2014) Lower carrier rate of GJB2 W24X ancestral Indian mutation in Roma samples from Hungary: implication for public health intervention. Mol Biol Rep 41(9):6105–6110CrossRef Sipeky C, Matyas P, Melegh M, Janicsek I, Szalai R, Szabo I, Varnai R, Tarlos G, Ganczer A, Melegh B (2014) Lower carrier rate of GJB2 W24X ancestral Indian mutation in Roma samples from Hungary: implication for public health intervention. Mol Biol Rep 41(9):6105–6110CrossRef
Metadata
Title
Age-Related Hearing Impairment Associated NAT2, GRM7, GRHL2 Susceptibility Gene Polymorphisms and Haplotypes in Roma and Hungarian Populations
Authors
Petra Matyas
Etelka Postyeni
Katalin Komlosi
Renata Szalai
Judit Bene
Lili Magyari
Bela Melegh
Kinga Hadzsiev
Publication date
01-10-2019
Publisher
Springer Netherlands
Published in
Pathology & Oncology Research / Issue 4/2019
Print ISSN: 1219-4956
Electronic ISSN: 1532-2807
DOI
https://doi.org/10.1007/s12253-018-0388-6

Other articles of this Issue 4/2019

Pathology & Oncology Research 4/2019 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine